Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Apimeds Pharmaceuticals US Wins Contract from AQUAE Holdings Pte. Ltd.
Apimeds Pharmaceuticals' subsidiary MindWave Innovations entered into two 12-month technology services agreements to deploy its MindChain blockchain infrastructure. The first agreement with AQUAE Holdings involves powering AQUAEChain for environmental credit management, while the second with Flash Sports & Media involves creating FlashChain for digital broadcasting rights and video assets.
Counterparty
AQUAE Holdings Pte. Ltd. and Flash Sports & Media Holdings, Inc.
Dynex Capital, Inc. closed an underwritten public offering of 4,800,000 shares of its 9.375% Series D Fixed-Rate Cumulative Redeemable Preferred Stock at a liquidation preference of $25.00 per share. The company raised $120 million in gross proceeds (excluding the underwriters' option for an additional 720,000 shares) to be used for general corporate purposes, including acquiring mortgage-backed securities.
Lifecore Biomedical, Inc. \De\ Wins Contract from Alcon Research, LLC
Lifecore Biomedical extended its contract manufacturing agreement with Alcon Research, LLC, pushing the expiration date from 2031 to December 31, 2034. The amendment establishes Alcon's minimum purchase obligations through the new term and includes a non-compete provision regarding certain products starting in November 2026.
Bluerock Acquisition Corp. II Capital Raise of $172M
Bluerock Acquisition Corp. II closed its initial public offering (IPO) of 17,250,000 units at $10.00 per unit, which included the full exercise of the underwriter's over-allotment option. The offering generated gross proceeds of $172.5 million for the newly formed blank check company (SPAC).
Dyne Therapeutics announced additional one-year clinical data from the Phase 1/2 ACHIEVE trial of z-basivarsen (DYNE-101) for myotonic dystrophy type 1 (DM1), showing sustained functional improvement in myotonia, strength, and mobility. The data showed a 3.6-second relative improvement in hand myotonia at 6 months compared to placebo and divergence from a matched natural history cohort at 12 months. The company remains on track to report topline data from its registrational expansion cohort in Q1 2027 to support a potential BLA submission for U.S. Accelerated Approval in Q3 2027.
Century Casinos Divestiture to Highfield Investment Group Inc. for $16.4M
Century Casinos entered into a definitive agreement to sell the racing and gaming operations of Century Mile and Century Downs in Alberta, Canada, to Highfield Investment Group for approximately $16.4 million. The deal includes an amendment to the company's master lease with VICI Properties, reducing Century's annual rent by approximately $7.5 million. The company intends to use the proceeds to reduce its indebtedness and focus on its U.S. growth opportunities.
VistaOne, L.P. sold unregistered limited partnership units for aggregate consideration of approximately $24.2 million as part of its continuous private offering. The sale included Class B, I, R, and S units to third-party investors, with the final unit counts determined based on the Fund's transactional net asset value as of August 31, 2026.
Fox Factory Holding Divestiture to Squared Up Holdings, LLC for $225M
Fox Factory Holding Corp. completed the divestiture of its Marucci Business (Wheelhouse Holdings Inc.) to Squared Up Holdings, LLC for an enterprise value of $225 million. The consideration consisted of $200 million in cash and a $25 million subordinated convertible promissory note, with the cash proceeds used to reduce the company's outstanding debt.
Polar Power Wins $60M Contract from Major Tier 1 telecom operator in Southeast Asia
Polar Power received a trial order for 50 propane-fueled DC generators from a major Southeast Asian telecom operator, marking the first phase of a potential five-year deployment program. The total opportunity covers approximately 2,500 sites and is estimated to be worth up to $60 million in revenue if the customer proceeds with the full rollout. The deal follows five years of technical evaluation and field testing aimed at reducing fuel and maintenance costs for off-grid cell sites.
Legacy Education Wins $60M Contract from Major Tier 1 telecom operator in Southeast Asia
Polar Power received a trial order for 50 propane-fueled DC generators from a major Southeast Asian telecom operator, representing the first phase of a potential five-year deployment program. If the customer proceeds with the full program covering 2,500 sites, the opportunity is estimated to represent approximately $60 million in revenue.
Athena Technology Acquisition Corp. II M&A Deal with Ace Green Recycling, Inc.
Athena Technology Acquisition Corp. II and Ace Green Recycling, Inc. entered into a waiver to their existing Business Combination Agreement to remove the requirement that SPAC warrants be listed on Nasdaq. The waiver was necessary because the warrants will not meet Nasdaq's minimum requirement of 100 round lot public holders.
Braemar Hotels & Resorts Divestiture to Evergreen Acquisitions, LLC for $372M
Braemar Hotels & Resorts Inc. entered into a definitive agreement to sell the Four Seasons Resort Scottsdale at Troon North to Evergreen Acquisitions, LLC for $372 million. The company has received a $10 million non-refundable deposit as part of the transaction, which remains subject to customary closing conditions.
Maison Solutions Inc. received a deficiency notice from Nasdaq on September 23, 2026, due to the late filing of its Quarterly Report on Form 10-Q and its Annual Report on Form 10-K. The company has until October 19, 2026, to submit a plan to regain compliance, which if accepted, could grant an extension until February 9, 2027.
Catalyst Bancorp M&A Deal with Lakeside Bancshares, Inc.
Catalyst Bancorp, Inc. filed a Form 8-K/A to provide required financial statements and pro forma information following its completed acquisition of Lakeside Bancshares, Inc. and Lakeside Bank. The filing includes audited financial statements for Lakeside for 2024-2025 and unaudited pro forma condensed combined financial statements as of March 31, 2026. This amendment supplements the original merger consummation report filed on July 14, 2026.
Adams Street Credit Solutions Fund raised approximately $350,000 through the sale of 17,386.585 Class I common shares in its September 2026 monthly closing. The shares were issued at a price of $20.13 per share, representing the fund's net asset value as of August 31, 2026. The fund also declared a monthly distribution of $0.15 per share for Class I shareholders of record as of September 24, 2026.
Silexion Therapeutics entered into an inducement agreement with warrant holders to exercise 3,216,928 existing warrants at a reduced price of $0.2603 per share. In exchange for the cash exercise, the company will issue 6,433,856 new Series F and G warrants to the holders. The transaction is expected to generate gross proceeds of approximately $0.84 million to support the company's operations.
Oncolytics Biotech announced the publication of preclinical data in the Proceedings of the National Academy of Sciences demonstrating that its immunotherapy candidate, pelareorep, can transform immunologically inactive liver cancer tumors into active ones. The data showed pelareorep increased CD8+ T cell density and PD-L1 expression, potentially making challenging tumor types more susceptible to checkpoint inhibitors and other immunotherapies.
Columbus Acquisition M&A Deal with WISeSat.Space Corp
Columbus Acquisition Corp, a SPAC, has adjourned its Extraordinary General Meeting of Shareholders to September 30, 2026. The meeting is intended to vote on the proposed business combination with WISeSat.Space Corp, and the adjournment provides additional time for the company to finalize the process.
CVC-PE Global Private Equity Fund Capital Raise of $79.9M
CVC-PE Global Private Equity Fund, LP raised approximately $79.9 million in aggregate consideration through the sale of unregistered limited partnership units on September 1, 2026. The capital raise was part of the Fund's continuous private offering, with units priced based on the Transactional Net Asset Value (NAV) as of August 31, 2026.
Creatd Signs $3.63M M&A Deal with C2 Capital Group, Inc. d/b/a C2 Live
Creatd, Inc. acquired a 10% equity stake in livestreaming platform C2 Live through a share exchange agreement valued at approximately $3.63 million. The company also signed a non-binding letter of intent to acquire the remaining 90% of C2 Live in the fourth quarter of 2026 as part of its AI and creator-driven growth strategy.
Liminatus Pharma has regained compliance with Nasdaq's minimum bid price requirement after its common stock maintained a closing bid price above $1.00 for 13 consecutive trading days. The company previously effected a 1-for-50 reverse stock split on August 20, 2026, to address the deficiency. Nasdaq has officially closed the matter, and the company remains listed on The Nasdaq Capital Market.
Cohen & Steers Income Opportunities REIT M&A Deal with Grand Canyon Crossing Shopping Center
Cohen & Steers Income Opportunities REIT (CNSREIT) has acquired Grand Canyon Crossing, a 99%-occupied shopping center in Phoenix, Arizona, anchored by a high-performing Walmart Supercenter. The acquisition was made through a programmatic joint venture with the Sterling Organization. The deal aligns with CNSREIT's strategy of investing in income-generating retail assets anchored by necessity-based tenants in high-growth markets.
uniQure N.V. released a clinical program update for AMT-130 (ifezuntirgene inilparvovec), its gene therapy candidate for Huntington’s disease. The update includes long-term data from ongoing Phase I/II clinical trials and details regarding the enrollment of a fourth cohort. The company is also evaluating neurofilament light chain (NfL) in cerebrospinal fluid as a potential biomarker for disease severity.
Moleculin Biotech has completed and closed enrollment for Part A of its pivotal Phase 2/3 MIRACLE trial evaluating Annamycin in combination with cytarabine (AnnAraC) for relapsed or refractory acute myeloid leukemia (R/R AML). The company enrolled 89 subjects and remains on track for a comprehensive data readout in the first quarter of 2027. The final Part A dataset is expected to provide efficacy insights across both 'fit' and 'unfit' patient populations, with an estimated 50/50 split between those previously treated with intensive chemotherapy versus venetoclax-based regimens.
Omniq Wins Contract from Two Pennsylvania municipalities
OMNIQ Corp. secured its first deployments in Pennsylvania through two-year agreements with two municipalities to implement its Q Shield™ Safe City platform for vehicle registration enforcement. The projects involve 18 cameras across nine intersections and utilize a citation-based processing fee model, creating a transaction-based recurring revenue stream for the company.
Counterparty
Two Pennsylvania municipalities (a borough and a township)
Global Business Travel Group Signs $6.3B M&A Deal with Long Lake Management
Global Business Travel Group (Amex GBT) completed its acquisition by Long Lake Management in an all-cash transaction valuing the company at approximately $6.3 billion. As a result of the merger, Amex GBT has become a privately held company and its Class A common stock will be delisted from the NYSE. The transaction was financed through a combination of equity from Long Lake investors and Koch Equity Development, along with a new $1.5 billion senior secured term loan facility.
Flash Sports & Media Holdings Wins $506K Contract from MindWave Innovations Inc.
Flash Sports & Media Holdings entered into a software development and technology services agreement with MindWave Innovations to build and operate 'FlashChain,' a dedicated blockchain network for sports media and ticketing. As consideration, the company will issue $506,000 in common stock and 20% of its FLASH TOKEN supply to MindWave. The partnership aims to authenticate digital broadcasting rights, video assets, and match-ticket inventory while preventing counterfeiting.
Keros Therapeutics Licensing Deal with Takeda Pharmaceuticals U.S.A., Inc. Worth $20M
Keros Therapeutics announced it will receive a $20 million development milestone payment from its partner Takeda following the dosing of the first patient in the Phase 3 ELRiSE MF clinical trial for elritercept. The payment is part of a global license agreement that includes potential milestones exceeding $1.1 billion. Keros intends to distribute 25% of the net cash proceeds from this milestone to its stockholders.
SurgePays received an additional 180-day extension from Nasdaq to regain compliance with the $1.00 minimum bid price requirement, extending the deadline to March 22, 2027. Separately, Nasdaq confirmed the company has regained compliance with the minimum stockholders' equity requirement. The company intends to cure the bid price deficiency by effecting a reverse stock split if necessary.
Soundthinking Signs $114M M&A Deal with Transom Capital Group, LLC
SoundThinking, Inc. has entered into a definitive agreement to be acquired by Transom Capital Group via a tender offer for $8.00 per share in cash plus a contingent value right (CVR) worth up to $3.00. The deal implies an upfront enterprise value of approximately $114 million, representing a 46% premium to the company's prior closing price, and will result in SoundThinking becoming a private company.